文献速递心脑血管急症重症综合管理与镇静镇痛

纤维蛋白原与A型急性主动脉夹层患者院内死亡率的关系

The relationship between fibrinogen and in-hospital mortality in patients with type A acute aortic dissection.
PubMed 文献 · Am J Emerg Med · 2017-10-11
一句话结论A型急性主动脉夹层患者入院纤维蛋白原低于2.17 g/L与院内死亡风险升高独立相关(OR 5.527)。

本研究连续纳入143例症状发作24小时内入院的A型急性主动脉夹层患者,入院时检测纤维蛋白原水平,终点为院内死亡。死亡组入院纤维蛋白原显著低于存活组(1.95 vs 2.37 g/L,p=0.001)。ROC曲线确定的纤维蛋白原截断值为2.17 g/L,敏感度71.9%、特异度60.4%,曲线下面积0.686(95%CI 0.585-0.768;p=0.001)。控制潜在混杂变量后,入院纤维蛋白原低于2.17 g/L者院内死亡风险高于纤维蛋白原大于2.17 g/L者(OR 5.527;95%CI 1.660-18.401;p=0.005)。

要点

  • A型急性主动脉夹层死亡组入院纤维蛋白原为1.95(1.37, 2.38)g/L,存活组为2.37(1.85, 3.15)g/L,死亡组显著更低(p=0.001)。
  • ROC曲线确定纤维蛋白原截断值2.17 g/L,敏感度71.9%、特异度60.4%,曲线下面积0.686(95%CI 0.585-0.768;p=0.001)。
  • 控制潜在混杂变量后,入院纤维蛋白原低于2.17 g/L者院内死亡风险高于大于2.17 g/L者(OR 5.527;95%CI 1.660-18.401;p=0.005)。
  • 入院低纤维蛋白原水平是A型急性主动脉夹层患者院内死亡的独立预测因素。

适用人群与场景

  • 连续纳入的症状发作24小时内入院的A型急性主动脉夹层患者。

诊断标准与关键阈值

  • 纤维蛋白原预测院内死亡的ROC曲线截断值为2.17 g/L,敏感度71.9%、特异度60.4%,曲线下面积0.686(95%CI 0.585-0.768;p=0.001)。

研究设计与关键结果

  • 研究类型为连续纳入A型急性主动脉夹层患者的队列研究,共143例,入院时检测纤维蛋白原,终点为院内死亡。
  • 死亡组入院纤维蛋白原为1.95(1.37, 2.38)g/L,存活组为2.37(1.85, 3.15)g/L,死亡组显著更低(p=0.001)。
  • ROC曲线确定纤维蛋白原截断值2.17 g/L,敏感度71.9%、特异度60.4%,曲线下面积0.686(95%CI 0.585-0.768;p=0.001)。
  • 控制潜在混杂变量后,入院纤维蛋白原低于2.17 g/L者院内死亡风险高于大于2.17 g/L者(OR 5.527;95%CI 1.660-18.401;p=0.005)。

证据类型、等级与局限

  • 证据类型为队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对A型急性主动脉夹层患者,入院纤维蛋白原低于2.17 g/L可能提示院内死亡风险升高,作者认为入院低纤维蛋白原水平是院内死亡的独立预测因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Fibrinogen plays an important role in hemostasis and thrombosis and is proven to have prognostic significance in patients with cardiovascular disease. We examined the utility of fibrinogen as a prognostic indicator for patients with type A acute aortic dissection (AAD).

METHODS: This study was performed in consecutive patients with type A AAD admitted to our hospital within 24 hours after onset of symptoms. Fibrinogen levels were measured on admission. Baseline clinical characteristics and laboratory test results were collected. The endpoint was in-hospital mortality.

RESULTS: A total of 143 patients with type A AAD were enrolled. Compared with the survivors, the nonsurvivors had significant lower fibrinogen levels (1.95(1.37, 2.38) vs. 2.37(1.85, 3.15) g/L, p=0.001). The cutoff level of fibrinogen determined by ROC curve analysis was 2.17 g/L, with a sensitivity, specificity of 71.9%, 60.4% respectively, and the area under the ROC curve was 0.686 (95% CI, 0.585-0.768; p=0.001). After controlling for potentially relevant confounding variables, we found an admission fibrinogen level less than 2.17g/L was associated with an increased risk of in-hospital mortality (odds ratio, 5.527; 95% CI, 1.660-18.401; p=0.005) compared with those with fibrinogen greater than 2.17g/L.

CONCLUSION: Low fibrinogen level on admission is an independent predictor of in-hospital mortality in patients with type A AAD.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Liu J, Sun LL, Wang J, et al. The relationship between fibrinogen and in-hospital mortality in patients with type A acute aortic dissection. Am J Emerg Med. 2017. PMID: 29055612. doi:10.1016/j.ajem.2017.10.001

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。